| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |